Seres Therapeutics, Inc. (MCRB)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 1.0300 |
| Open | 1.0500 |
| Bid | 1.0000 x 4400 |
| Ask | 1.0200 x 200 |
| Day's range | 0.9650 - 1.0800 |
| 52-week range | 0.5400 - 6.2600 |
| Volume | |
| Avg. volume | 4,945,641 |
| Market cap | 154.029M |
| Beta (5Y monthly) | 2.14 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.8900 |
| Earnings date | 06 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 6.20 |
Simply Wall St.Seres Therapeutics First Quarter 2024 Earnings: US$0.28 loss per share (vs US$0.56 loss in 1Q 2023)
Seres Therapeutics ( NASDAQ:MCRB ) First Quarter 2024 Results Key Financial Results Net loss: US$40.1m (loss narrowed...
- GuruFocus.com
Seres Therapeutics Inc (MCRB) Q1 2024 Earnings Call Transcript Highlights: Strategic Insights ...
Unveiling key financial results and strategic directions, including the impactful launch of VOWST and promising developments in SER-155.
- GuruFocus.com
Seres Therapeutics Reports Q1 2024 Earnings: Surpasses Revenue Estimates
Financial Highlights and Strategic Updates
© 2024 Yahoo. All rights reserved.